These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2274687)

  • 1. A single oral dose method for predicting steady state theophylline concentrations in clinical practice.
    Mann JS; Fitzpatrick RW; Jones PW; Prowse K; Mucklow JC; Cole RB
    Respir Med; 1990 Nov; 84(6):479-84. PubMed ID: 2274687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of absorption rate models in the prediction of steady-state plasma concentrations during oral theophylline administration.
    Paterson CM; Hudson SA; Jefferson GC
    J Clin Pharm Ther; 1987 Feb; 12(1):39-46. PubMed ID: 3449562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualization of theophylline dosage: a Bayesian method evaluated in patients with once-daily dosing.
    Martz W; Oellerich M; Schnabel D; Sybrecht GW
    Ther Drug Monit; 1991 Sep; 13(5):420-4. PubMed ID: 1957334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease.
    Taylor DR; Duffin D; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1984 Jul; 18(1):27-30. PubMed ID: 6743488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.
    Horai Y; Ishizaki T; Sasaki T; Watanabe M; Kabe J
    Eur J Clin Pharmacol; 1982; 23(2):111-21. PubMed ID: 7140800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of theophylline treatment in patients handicapped by chronic obstructive lung disease.
    McKay SE; Howie CA; Thomson AH; Whiting B; Addis GJ
    Thorax; 1993 Mar; 48(3):227-32. PubMed ID: 8497820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of maintenance oral theophylline dosage using single oral doses in patients with obstructive airways disease.
    Taylor DR; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1983 Nov; 16(5):511-6. PubMed ID: 6639837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of optimum oral theophylline dose in patients with obstructive airways disease.
    Taylor DR; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1983 Jun; 15(6):689-94. PubMed ID: 6871068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline steady-state pharmacokinetics: recent concepts and their application in chronotherapy of reactive airway diseases.
    Steinijans VW; Trautmann H; Johnson E; Beier W
    Chronobiol Int; 1987; 4(3):331-47. PubMed ID: 3315264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state pharmacokinetics of theophylline in COPD patients treated with dirithromycin.
    Bachmann K; Jauregui L; Sides G; Sullivan TJ
    J Clin Pharmacol; 1993 Sep; 33(9):861-5. PubMed ID: 8227485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dosing time on the pharmacokinetics and pharmacodynamics of a 'once-a-day' sustained release theophylline preparation.
    Lamont H; Pauwels R; Van der Straeten M
    Br J Clin Pharmacol; 1987 Dec; 24(6):735-42. PubMed ID: 3440095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multicenter study with a large number of patients for the validation of pharmacokinetic and clinical findings from controlled studies with small patient cohorts].
    Götz JK; Sauter R
    Pneumologie; 1991 Nov; 45 Suppl 4():867-74. PubMed ID: 1812482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times.
    Chrystyn H; Ellis JW; Mulley BA; Peake MD
    Br J Clin Pharmacol; 1989 Feb; 27(2):215-21. PubMed ID: 2713215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dose titration with Euphylong following prior determination of serum concentration in the steady state].
    Schnabel D; von Treufels S; Oellerich M; Böttger HC; Sybrecht GW
    Pneumologie; 1990 Feb; 44 Suppl 1():287-8. PubMed ID: 2367392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily maintenance dose of a long-acting theophylline from a single theophylline serum level.
    Goldstein RS; Allen LC; Thiessen JJ; Michalko K; Dayneka N; Woolf CR
    Chest; 1986 Jan; 89(1):103-8. PubMed ID: 3940768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily dosing of a new ultrasustained-release theophylline preparation.
    Van den Brande P; Nys J; Tjandramaga TB; Verhelst F; Demedts M
    Respiration; 1987; 52(2):144-53. PubMed ID: 3671893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A single dose of theophylline in the evening in chronic obstructive airway disease. Serum concentration and lung function parameter].
    Kaik G
    Fortschr Med; 1984 Nov; 102(43):1120-2. PubMed ID: 6510864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of serum theophylline levels.
    Elenbaas RM; Payne VW
    Ann Emerg Med; 1984 Feb; 13(2):92-6. PubMed ID: 6691624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship among dosages of aminophylline, plasma levels of theophylline and variation of pulmonary arterial pressure].
    Liu S; Chen W; Luo Y; Yuan Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):87-90. PubMed ID: 1398633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of plasma levels of 2 delayed-action theophyllines: Theostat 200 and Theodur 200, after a single evening dose].
    Philip-Joet F; Bruguerolle B; Lagier F; Arnaud A
    Rev Pneumol Clin; 1986; 42(6):279-83. PubMed ID: 3563255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.